Affordable Access

deepdyve-link
Publisher Website

Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.

Authors
  • Clark, Beth Z1
  • Farrugia, Daniel J2, 3
  • Landmann, Alessandra2, 4
  • Diego, Emilia J2
  • Dabbs, David J1
  • Puhalla, Shannon L5
  • Jankowitz, Rachel C5
  • Brufsky, Adam M5
  • Ahrendt, Gretchen M2, 6
  • McAuliffe, Priscilla F2
  • Bhargava, Rohit1
  • 1 Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • 2 Department of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA.
  • 3 Centegra Comprehensive Breast Program, Centegra Health System, Crystal Lake, IL.
  • 4 College of Medicine, Department of Surgery, University of Oklahoma, Oklahoma City.
  • 5 Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
  • 6 Department of Surgery, University of Colorado, Aurora.
Type
Published Article
Journal
American Journal of Clinical Pathology
Publisher
Oxford University Press
Publication Date
Feb 22, 2018
Identifiers
DOI: 10.1093/ajcp/aqx168
PMID: 29481634
Source
Medline
License
Unknown

Abstract

Both mRDBN and gRDBN provide prognostic information, particularly in HER2-negative carcinoma; however, mRDBN showed better stratification of RDBN-3 and RDBN-4 patients.

Report this publication

Statistics

Seen <100 times